Vaccinia virus
Vaccinia virus
规格:
货期:
编号:TS168483
品牌:Testobio
| 产品名称： | Vaccinia virus |
|---|---|
| 商品货号： | TS168483 |
| Classification： | Poxviridae, Orthopoxvirus |
| Agent： | Vaccinia virus |
| Strain： | vTF7HB-1 recombinant Vaccinia virus, strain Wr |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation： | Constructed in vitro |
| Product Format： | frozen |
| Storage Conditions： | -60°C or colder |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Comments： | Contains hepatitis B surface antigen gene regulated by bacteriophage T7 promoter. |
| Effect on Host： | Cytopathic effects in tissue culture |
| Name of Depositor： | NIH, B Moss, NIH |
| U.S. Patent： | |
| U.S. Patent Number： | |
| Source： | Constructed in vitro |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
Vaccinia virus
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Vaccinia virus |
|---|---|
| 商品货号： | TS168483 |
| Classification： | Poxviridae, Orthopoxvirus |
| Agent： | Vaccinia virus |
| Strain： | vTF7HB-1 recombinant Vaccinia virus, strain Wr |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation： | Constructed in vitro |
| Product Format： | frozen |
| Storage Conditions： | -60°C or colder |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Comments： | Contains hepatitis B surface antigen gene regulated by bacteriophage T7 promoter. |
| Effect on Host： | Cytopathic effects in tissue culture |
| Name of Depositor： | NIH, B Moss, NIH |
| U.S. Patent： | |
| U.S. Patent Number： | |
| Source： | Constructed in vitro |
